We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02661282
Recruitment Status : Recruiting
First Posted : January 22, 2016
Last Update Posted : March 14, 2018
Marnie Rose Foundation
Gateway for Cancer Research
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2020
  Estimated Study Completion Date : June 2021